Fingerprint
Dive into the research topics of 'Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome
Sergio Martinez-Høyer, Yu Deng, Jeremy Parker, Jihong Jiang, Angela Mo, T. Roderick Docking, Nadia Gharaee, Jenny Li, Patricia Umlandt, Megan Fuller, Martin Jädersten, Austin Kulasekararaj, Luca Malcovati, Alan F. List, Eva Hellström-Lindberg, Uwe Platzbecker, Aly Karsan*
*Corresponding author for this work
- British Columbia Cancer Research Centre
- Erasmus University Medical Center
- Vancouver General Hospital, The Prostate Centre, University of British Columbia, Faculty of Medicine
- Karolinska University Hospital
- King's College Hospital
- University of Pavia
- H. Lee Moffitt Cancer Center and Research Institute
- Medical Clinic and Policlinic 1
- University Hospital Leipzig
Research output: Contribution to journal › Article › peer-review
32
Citations
(Scopus)